Ginkgo Bioworks Holdings

$3.40 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug deoxyribonucleic acid (DNA) code in engineered organisms to execute programs for its customers. Its platform is used by customers for manufacturing processes or develop new products through biology. The foundation of its platform includes two assets that execute a variety of cell programs for customers according to their specifications: Foundry and Codebase. It serves industries, including chemicals, agriculture, food, consumer products and pharmaceuticals.

Stock Analysis

last close $3.4
1-mo return 13.7%
3-mo return 54.5%
avg daily vol. 24.39M
52-week high 15.86
52-week low 2.09
market cap. $3.4B
forward pe -
annual div. -
roe -186.1%
ltg forecast -
dividend yield -
annual rev. $438M
inst own. 80.2%
baraka

Subscribe now for daily local and international financial news

Subscribe